Anastomosis Devices Industry Overview

The global anastomosis devices market size was estimated at USD 3.98 billion in 2023 and is projected to grow at a CAGR of 5.6% from 2024 to 2030.

The increase in the number of surgical procedures, a rise in the prevalence of chronic diseases and technological advancements in anastomosis devices are the key trends driving the market growth. Lifestyle-related conditions such as cardiac diseases, diabetes, hypertension, obesity, and cancer are contributing to the growth in demand for these devices. According to the article published by the National Center for Chronic Disease Prevention Health Promotion, in August 2023, approximately 60% of the population living in the U.S. were suffering from at least one chronic condition such as heart ailment, cancer, stroke, and diabetes.

Gather more insights about the market drivers, restrains and growth of the Anastomosis Devices Market

The rising number of surgical procedures, such as Coronary Artery Bypass Graft (CABG), organ transplantation surgery, dialysis access surgery, intestinal bypass surgery, and colectomy, is anticipated to drive market growth over the forecast period. With the growing prevalence of cardiovascular heart diseases, a large number of CABG surgeries are being conducted. The study published by the National Library of Medicine in August 2023 reports that CABG is the most typical surgical process, and around 400,000 CABG surgeries are performed annually. Moreover, the growing number of individuals undergoing organ transplantations is also expected to boost the demand for anastomosis devices over the forecast period. According to the article published by the United Network for Organ Sharing, in January 2023, around 42,887 organ transplants were performed in the U.S. in 2022, which demonstrated an increase of 3.7% over 2021.

Technological advancements, such as developing novel products by modifying shapes and designs, are anticipated to increase the adoption of anastomosis devices. In addition, key manufacturers are using various technologies such as 3D stapling technology, gripping surface technology, and tri-staple technology in these devices. Major companies in the market are focusing on developing innovative devices and technologies that can be used for anastomosis. For instance, in January 2022, Seger Surgical Solutions initiated the development of its laparoscopic bowel closure device, LAP IA 60, for intracorporeal anastomosis. This device can close, align, and staple the common opening for intracorporeal anastomosis securely, quickly, and without the requirement for suturing. This next-generation device can close the enterotomy within two minutes. Such product advancements are expected to boost the adoption of anastomosis devices in the coming decade.

Moreover, the demand for anastomosis devices is also expected to increase due to the growing geriatric population and healthcare expenditure. According to the National Bureau of Statistics of China, in 2023, individuals aged 60 above accounted for 19.8% of the population. Around 330 million individuals in China are affected by CVDs, 45.3 million by peripheral artery disease, 11.39 million by coronary heart disease, including 13 million strokes, 5 million pulmonary heart disease, 4.87 million atrial fibrillation, 2.5 million rheumatic heart disease, 8.9 million heart failure, 2 million congenital heart disease, and 245 million hypertension cases. This rising prevalence of cardiovascular conditions among the population needs surgical attention, which is expected to drive the market growth of anastomosis devices.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global coronary artery bypass graft market size was valued at USD 12.980 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2030.
• The global tobacco market size was estimated at USD 886.09 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2030 due to the rising tobacco consumption in the developing regions of Asia and Africa.

Anastomosis Devices Market Segmentation

Grand View Research has segmented the global anastomosis devices market based on product, application and end-use:

Anastomosis Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Disposable
• Reusable

Anastomosis Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular Surgery
• Gastrointestinal Surgery
• Others

Anastomosis Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Care Centers and Clinics

Anastomosis Devices Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Medtronic
• Mizuho Medical Co., Ltd (MIZUHO Corporation)
• Getinge
• Peters Surgical
• Baxter
• ETHICON, Inc. (Johnson Johnson Services, Inc)
• Carponovum AB
• VASCULAR GRAFT SOLUTIONS LTD
• Medline Industries, LP
• Seger Surgical Solutions

Key Anastomosis Devices Company Insights

Some of the key players operating in the market include Medtronic; Ethicon US, LLC; Peters Surgical. s

• Medtronic is a global company in medical technology, solutions and services which offers a range of anastomosis devices through its minimally invasive therapies group. Medtronic’s anastomosis devices portfolio includes products such as LigaSure, Signia Stapling System, DuraSeal, Vessel Sealers and Handheld Surgical Staplers
• Mizuho Medical Co., Ltd is a medical devices company that specializes in medical devices, including products for surgical procedures such as anastomosis. Mizuho Medical Co., Ltd offers a diverse portfolio of anastomosis devices, including staplers, sutures, and other specialized instruments used in surgical procedures.

Recent Developments

• In April 2022, the Synovis Micro Companies Alliance, Inc., a subsidiary of Baxter, received approval from the U.S. FDA for its GEM FLOW COUPLER Monitor device. This device is useful in the end-to-end anastomosis of veins and arteries.
• In January 2022, Seger Surgical Solutions Ltd. initiated the development of LAP IA 60, an intracorporeal anastomosis laparoscopic device.
• In March 2021, ETHICON, Inc. (Johnson Johnson Services, Inc) introduced a new powered surgical stapler, the ECHELON+ Stapler with GST Reloads. This product can improve staple line security lower intricacies through better staple formation and uniform tissue compression.

Order a free sample PDF of the Anastomosis Devices Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.